We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+8.36%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$3.16B
AUM Growth
+$1.67B
(+111%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
50.65%
Top 10 Holdings %
Top 10 Hldgs %
65.71%
Holding
52
New
14
Increased
12
Reduced
13
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boise Cascade
BCC
|
+$61.5M |
| 2 |
Insulet
PODD
|
+$53.2M |
| 3 |
Cigna
CI
|
+$46.5M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$38.7M |
| 5 |
MGM Resorts International
MGM
|
+$37.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$71.4M |
| 2 |
Accuray
ARAY
|
+$36.3M |
| 3 |
Zoetis
ZTS
|
+$27.2M |
| 4 |
Tenet Healthcare
THC
|
+$26.1M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$25.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.2% |
| 2 | Consumer Discretionary | 4.58% |
| 3 | Communication Services | 3.49% |
| 4 | Consumer Staples | 2.84% |
| 5 | Financials | 2.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PennyMac Financial
PFSI
$3.91B
| $33.1M | 1.05% |
1,826,960
-198,040
| -10% | -$3.61M |
|
27
Humana
HUM
$44.1B
| $32.3M | 1.02% |
168,809
-132,415
| -44% | -$24.6M |
|
28
Cardiff Oncology
CRDF
$65.9M
| $32M | 1.01% |
43,758
+4,167
| +11% | +$2.96M |
|
29
Ironwood Pharmaceuticals
IRWD
$688M
| $30.3M | 0.96% |
2,997,003
+1,993,471
| +199% | +$23.2M |
|
30
Centene
CNC
$30.7B
| $29.9M | 0.95% |
744,196
-312,156
| -30% | -$11.2M |
|
31
Eli Lilly
LLY
$1.02T
| $29.2M | 0.92% |
349,591
-17,302
| -5% | -$1.32M |
|
32
Regeneron Pharmaceuticals
REGN
$77.6B
| $27.6M | 0.87% |
+54,132
| New | +$26.4M |
|
33
Atara Biotherapeutics
ATRA
$74.4M
| $26.4M | 0.84% |
20,052
+1,059
| +6% | +$1.21M |
|
34
TG Therapeutics
TGTX
$8B
| $25.5M | 0.81% |
1,537,529
-514,292
| -25% | -$8.14M |
|
35
Liberty Broadband Class A
LBRDA
$4.9B
| $17.6M | 0.56% |
+345,680
| New | +$18.4M |
|
36
CALL
Alerian MLP ETF
AMLP
$13B
| $15.6M | 0.49% |
200,000
| – | – |
|
|
DYAX
37
DELISTED
DYAX CORPORATION
DYAX
| $13.9M | 0.44% |
+523,157
| New | +$13.9M |
|
38
Cameco
CCJ
$37.7B
| $11.6M | 0.37% |
813,586
| – | – |
|
|
AMRI
39
DELISTED
Albany Molecular Research Inc
AMRI
| $11.3M | 0.36% |
558,818
+158,762
| +40% | +$3.06M |
|
|
SGYP
40
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $7.03M | 0.22% |
+847,094
| New | +$4.11M |
|
|
BKI
41
DELISTED
Black Knight, Inc. Common Stock
BKI
| $6.66M | 0.21% |
+215,700
| New | +$6.23M |
|
42
Lexicon Pharmaceuticals
LXRX
$1.03B
| $2.09M | 0.07% |
+259,458
| New | +$1.91M |
|
|
RGDX
43
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
| $1.96M | 0.06% |
6,000,000
| – | – |
|
|
ALPN
44
DELISTED
Alpine Immune Sciences Inc
ALPN
| $452K | 0.01% |
+8,290
| New | +$494K |
|
|
45
Accuray
ARAY
$31.5M
| – | – |
-3,903,090
| Closed | -$36.3M |
|
46
Arrowhead Research
ARWR
$12B
| – | – |
-2,976,183
| Closed | -$20.1M |
|
47
Casella Waste Systems
CWST
$5.65B
| – | – |
-544,220
| Closed | -$2.99M |
|
|
48
Morgan Stanley
MS
$332B
| – | – |
-2,000,000
| Closed | -$71.4M |
|
|
49
Teva Pharmaceuticals
TEVA
$40.9B
| – | – |
-406,756
| Closed | -$25.3M |
|
|
50
Tenet Healthcare
THC
$20.5B
| – | – |
-527,088
| Closed | -$26.1M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q2 2015 Portfolio in Review
As of Q2 2015, Bridger Management held 52 positions worth $3.16B, up 111% from $1.5B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Bridger Management deployed $1.6B of net new capital in Q2 2015, opening 14 new positions and adding to 12 existing holdings. Its largest new stake was Boise Cascade: 1,680,672 shares worth $61.6M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 58% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Zoetis, an estimated $27.2M trimmed.
- Bridger Management's largest Q2 2015 buy was Boise Cascade: 1,680,672 shares worth $61.6M.
- Bridger Management added most to HCA Healthcare in Q2 2015, an estimated $27.1M increase.
- Bridger Management's biggest Q2 2015 reduction was Zoetis, cutting an estimated $27.2M.
- Bridger Management fully exited Morgan Stanley in Q2 2015, selling an estimated $71.4M.
- Bridger Management's ten largest holdings make up 66% of its $3.16B portfolio in Q2 2015.
- Bridger Management opened 14 new positions and closed 8 in Q2 2015.
- Bridger Management's portfolio value rose 111% quarter-over-quarter to $3.16B.
Based on Bridger Management's 13F filing for Q2 2015, filed 14 Aug 2015.